In a report released today, Owen Bennett from Jefferies maintained a Hold rating on Cronos Group (CRON – Research Report), with a price target of C$3.54. The company’s shares closed today at $2.92.
According to TipRanks, Bennett is an analyst with an average return of -8.6% and a 39.74% success rate. Bennett covers the Healthcare sector, focusing on stocks such as OrganiGram Holdings, Cronos Group, and Aurora Cannabis.
Currently, the analyst consensus on Cronos Group is a Hold with an average price target of $2.76.
The company has a one-year high of $3.14 and a one-year low of $1.64. Currently, Cronos Group has an average volume of 3.45M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cronos Group (CRON) Company Description:
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
Read More on CRON:
- DOJ set to post plans for marijuana reclassification, Politico says
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Cronos Group price target raised to $3.50 from $3 at CIBC
- Cronos Group price target raised to C$4.25 from C$3.75 at Canaccord
- Rising High: Exclusive talk with Dazed Cannabis
